annual cash & cash equivalents:
$5.55B-$7.26B(-56.66%)Summary
- As of today (September 17, 2025), ABBV annual cash & cash equivalents is $5.55 billion, with the most recent change of -$7.26 billion (-56.66%) on December 31, 2024.
- During the last 3 years, ABBV annual cash & cash equivalents has fallen by -$4.28 billion (-43.49%).
- ABBV annual cash & cash equivalents is now -86.09% below its all-time high of $39.92 billion, reached on December 31, 2019.
Performance
ABBV Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$6.47B+$1.29B(+24.94%)Summary
- As of today (September 17, 2025), ABBV quarterly cash & cash equivalents is $6.47 billion, with the most recent change of +$1.29 billion (+24.94%) on June 30, 2025.
- Over the past year, ABBV quarterly cash & cash equivalents has dropped by -$6.69 billion (-50.85%).
- ABBV quarterly cash & cash equivalents is now -84.28% below its all-time high of $41.14 billion, reached on March 31, 2020.
Performance
ABBV quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABBV Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.7% | -50.9% |
| 3 y3 years | -43.5% | -35.1% |
| 5 y5 years | -86.1% | +7.1% |
ABBV Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.7% | at low | -64.2% | +24.9% |
| 5 y | 5-year | -86.1% | at low | -64.2% | +24.9% |
| alltime | all time | -86.1% | +749.9% | -84.3% | >+9999.0% |
ABBV Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.47B(+24.9%) |
| Mar 2025 | - | $5.18B(-6.8%) |
| Dec 2024 | $5.55B(-56.7%) | $5.55B(-23.7%) |
| Sep 2024 | - | $7.29B(-44.6%) |
| Jun 2024 | - | $13.16B(-27.2%) |
| Mar 2024 | - | $18.07B(+41.0%) |
| Dec 2023 | $12.82B(+38.9%) | $12.82B(-3.6%) |
| Sep 2023 | - | $13.29B(+51.6%) |
| Jun 2023 | - | $8.77B(+30.4%) |
| Mar 2023 | - | $6.72B(-27.2%) |
| Dec 2022 | $9.23B(-6.1%) | $9.23B(-22.3%) |
| Sep 2022 | - | $11.88B(+19.3%) |
| Jun 2022 | - | $9.96B(+31.6%) |
| Mar 2022 | - | $7.57B(-23.0%) |
| Dec 2021 | $9.83B(+15.9%) | $9.83B(-19.7%) |
| Sep 2021 | - | $12.25B(+42.4%) |
| Jun 2021 | - | $8.60B(-12.0%) |
| Mar 2021 | - | $9.78B(+15.3%) |
| Dec 2020 | $8.48B(-78.8%) | $8.48B(+6.7%) |
| Sep 2020 | - | $7.95B(+31.6%) |
| Jun 2020 | - | $6.04B(-85.3%) |
| Mar 2020 | - | $41.14B(+3.1%) |
| Dec 2019 | $39.92B(+395.3%) | $39.92B(+274.9%) |
| Sep 2019 | - | $10.65B(+96.6%) |
| Jun 2019 | - | $5.42B(+3.6%) |
| Mar 2019 | - | $5.23B(-35.1%) |
| Dec 2018 | $8.06B | $8.06B(-8.2%) |
| Sep 2018 | - | $8.79B(+134.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $3.74B(-60.5%) |
| Mar 2018 | - | $9.47B(-3.2%) |
| Dec 2017 | $9.79B(+52.4%) | $9.79B(+2.5%) |
| Sep 2017 | - | $9.55B(+32.6%) |
| Jun 2017 | - | $7.21B(+15.3%) |
| Mar 2017 | - | $6.25B(-2.7%) |
| Dec 2016 | $6.42B(-23.6%) | $6.42B(-19.2%) |
| Sep 2016 | - | $7.95B(-0.6%) |
| Jun 2016 | - | $8.00B(-7.0%) |
| Mar 2016 | - | $8.60B(+2.3%) |
| Dec 2015 | $8.41B(+0.4%) | $8.41B(-9.1%) |
| Sep 2015 | - | $9.25B(+11.7%) |
| Jun 2015 | - | $8.28B(+4.5%) |
| Mar 2015 | - | $7.92B(-5.4%) |
| Dec 2014 | $8.37B(-15.4%) | $8.37B(-18.9%) |
| Sep 2014 | - | $10.32B(+0.8%) |
| Jun 2014 | - | $10.25B(+12.6%) |
| Mar 2014 | - | $9.10B(-8.0%) |
| Dec 2013 | $9.89B(+24.1%) | $9.89B(+3.1%) |
| Sep 2013 | - | $9.60B(+9.6%) |
| Jun 2013 | - | $8.75B(+17.0%) |
| Mar 2013 | - | $7.48B(-6.2%) |
| Dec 2012 | $7.98B(+1120.4%) | $7.98B(+73.9%) |
| Sep 2012 | - | $4.59B(+6052.1%) |
| Jun 2012 | - | $74.54M(+73.4%) |
| Mar 2012 | - | $42.99M(-93.4%) |
| Dec 2011 | $653.58M(-65.3%) | $653.58M |
| Dec 2010 | $1.88B | - |
FAQ
- What is AbbVie Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AbbVie Inc.?
- What is AbbVie Inc. annual cash & cash equivalents year-on-year change?
- What is AbbVie Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for AbbVie Inc.?
- What is AbbVie Inc. quarterly cash & cash equivalents year-on-year change?
What is AbbVie Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ABBV is $5.55B
What is the all time high annual cash & cash equivalents for AbbVie Inc.?
AbbVie Inc. all-time high annual cash & cash equivalents is $39.92B
What is AbbVie Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ABBV annual cash & cash equivalents has changed by -$7.26B (-56.66%)
What is AbbVie Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ABBV is $6.47B
What is the all time high quarterly cash & cash equivalents for AbbVie Inc.?
AbbVie Inc. all-time high quarterly cash & cash equivalents is $41.14B
What is AbbVie Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ABBV quarterly cash & cash equivalents has changed by -$6.69B (-50.85%)